Floatz logo

Topical Dapsone 5% Gel

Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma

Memorial Sloan Kettering Cancer CenterPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma cohort.

Asset / SponsorPhaseRating
METRONIDAZOLE
Memorial Sloan Kettering Cancer Center
Phase 3BB
Dapsone
Memorial Sloan Kettering Cancer Center
Phase 3BB
NEOMYCIN
Memorial Sloan Kettering Cancer Center
Phase 3BB

Same molecule, other indications

Topical Dapsone 5% Gel is also rated in:

acneiform dermatitisDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →